We are pleased to inform you that the Board of Directors of the Company in their meeting held on Thursday, September 25, 2025, at the Registered Office of the Company situated at 3B, Patanwala ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories' Board of Directors met on September 25, 2025, at the company's registered office in Ghatkopar, Mumbai. The meeting ran from 12:30 PM to 2:05 PM. The only substantive item transacted was the approval of the Cost Audit Report (Form CRA-3) for the financial year 2024-2025. This is a routine regulatory compliance requirement under the Companies Act for companies in certain manufacturing sectors, including pharmaceuticals. No other business, financial results, or strategic decisions were disclosed in this filing.
This is a routine compliance filing with no material impact on shareholders or stock price. The approval of the Cost Audit Report is a standard annual regulatory requirement and does not signal any change in business outlook, earnings, or strategy.